191 related articles for article (PubMed ID: 2572298)
1. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: pharmacological characterization.
Lysko PG; Cox JA; Vigano MA; Henneberry RC
Brain Res; 1989 Oct; 499(2):258-66. PubMed ID: 2572298
[TBL] [Abstract][Full Text] [Related]
2. N-methyl-D-aspartate promotes the survival of cerebellar granule cells: pharmacological characterization.
Balázs R; Hack N; Jørgensen OS; Cotman CW
Neurosci Lett; 1989 Jul; 101(3):241-6. PubMed ID: 2549463
[TBL] [Abstract][Full Text] [Related]
3. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
Widdowson PS; Gyte AJ; Upton R; Wyatt I
Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
[TBL] [Abstract][Full Text] [Related]
4. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: role of the voltage-dependent magnesium block.
Cox JA; Lysko PG; Henneberry RC
Brain Res; 1989 Oct; 499(2):267-72. PubMed ID: 2572299
[TBL] [Abstract][Full Text] [Related]
5. N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells.
Chuang DM; Gao XM; Paul SM
Mol Pharmacol; 1992 Aug; 42(2):210-6. PubMed ID: 1355259
[TBL] [Abstract][Full Text] [Related]
6. Serum and depolarizing agents cause acute neurotoxicity in cultured cerebellar granule cells: role of the glutamate receptor responsive to N-methyl-D-aspartate.
Schramm M; Eimerl S; Costa E
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1193-7. PubMed ID: 2153974
[TBL] [Abstract][Full Text] [Related]
7. 3-Nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons.
Weller M; Paul SM
Eur J Pharmacol; 1993 Oct; 248(3):223-8. PubMed ID: 7904944
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of dopamine release from cultured rat mesencephalic cells by naturally occurring excitatory amino acids: involvement of both N-methyl-D-aspartate (NMDA) and non-NMDA receptor subtypes.
Mount H; Quirion R; Chaudieu I; Boksa P
J Neurochem; 1990 Jul; 55(1):268-75. PubMed ID: 1972390
[TBL] [Abstract][Full Text] [Related]
9. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.
Boje KM; Wong G; Skolnick P
Brain Res; 1993 Feb; 603(2):207-14. PubMed ID: 8096423
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the potency of competitive NMDA antagonists against the neurotoxicity of glutamate and NMDA.
Speliotes EK; Hartnett KA; Blitzblau RC; Aizenman E; Rosenberg PA
J Neurochem; 1994 Sep; 63(3):879-85. PubMed ID: 7914224
[TBL] [Abstract][Full Text] [Related]
11. Glutamate receptors of the N-methyl-D-aspartate subtype in the myenteric plexus of the guinea pig ileum.
Shannon HE; Sawyer BD
J Pharmacol Exp Ther; 1989 Nov; 251(2):518-23. PubMed ID: 2572691
[TBL] [Abstract][Full Text] [Related]
12. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
Foster AC; Wong EH
Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
[TBL] [Abstract][Full Text] [Related]
13. Labeling of NMDA receptor channels by [3H]MK-801 in brain synaptic membranes treated with Triton X-100.
Yoneda Y; Ogita K
Brain Res; 1989 Oct; 499(2):305-14. PubMed ID: 2572302
[TBL] [Abstract][Full Text] [Related]
14. Non-competitive antagonists of N-methyl-D-aspartate receptors protect cortical and hippocampal cell cultures against glutamate neurotoxicity.
Rondouin G; Drian MJ; Chicheportiche R; Kamenka JM; Privat A
Neurosci Lett; 1988 Aug; 91(2):199-203. PubMed ID: 2903469
[TBL] [Abstract][Full Text] [Related]
15. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
Kurumaji A; Nehls DG; Park CK; McCulloch J
Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells.
Sparapani M; Dall'Olio R; Gandolfi O; Ciani E; Contestabile A
Exp Neurol; 1997 Nov; 148(1):157-66. PubMed ID: 9398458
[TBL] [Abstract][Full Text] [Related]
17. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor.
Olmos G; DeGregorio-Rocasolano N; Paz Regalado M; Gasull T; Assumpció Boronat M; Trullas R; Villarroel A; Lerma J; García-Sevilla JA
Br J Pharmacol; 1999 Jul; 127(6):1317-26. PubMed ID: 10455281
[TBL] [Abstract][Full Text] [Related]
18. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
[TBL] [Abstract][Full Text] [Related]
19. Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801.
Hahn JS; Aizenman E; Lipton SA
Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6556-60. PubMed ID: 2901101
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system.
Nehls DG; Kurumaji A; Park CK; McCulloch J
Neurosci Lett; 1988 Aug; 91(2):204-10. PubMed ID: 2847086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
